Aclaris Therapeutics
ACRS
ACRS
57 hedge funds and large institutions have $65M invested in Aclaris Therapeutics in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
45% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 22
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
57
Holding in Top 10
1
Calls
$69K
Puts
$1K
Top Buyers
| 1 | +$1.76M | |
| 2 | +$1.11M | |
| 3 | +$1.02M | |
| 4 |
Renaissance Technologies
New York
|
+$395K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$373K |
Top Sellers
| 1 | -$5.41M | |
| 2 | -$1.17M | |
| 3 | -$761K | |
| 4 |
TI
Telemetry Investments
New York
|
-$530K |
| 5 |
Jane Street
New York
|
-$445K |